Uroplasty, Inc. (UPST)'s OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 12/11/2009
More...
|
Asia's Party Drug Ketamine Carries Incontinence Risk 6/26/2009
More...
|
Gel Effective For Women With Overactive Bladder, Vanderbilt University Medical Center Study 5/5/2009
More...
|
Women Sue Over Mentor Corporation (MNTR) Device to Stop Urine Leaks 5/5/2009
More...
|
Muscle Cells Cut Urinary Incontinence, University of Toronto Study 4/27/2009
More...
|
Genetic Disease Commonly Misdiagnosed as Urological Disorder Leads to Unnecessary Surgery in 75% of Cases: Adult Polyglucosan Body Disease Research Foundation Advises Prostate Patients to Get Tested for APBD Before Surgery 12/10/2008
More...
|
Orelle Corporation Announces Conclusion of Phase II Clinical Trials 7/3/2008
More...
|
Urodynamix Technologies Ltd. (URO.V) And Laborie Medical Technologies Launch Tetra(TM) Bladder Monitor System - A Revolution In Bladder Diagnostics 5/27/2008
More...
|
New Category Of Device For Stone Extraction To Help Render Patients Free From Kidney Stones And Stones In The Urinary Tract 5/9/2008
More...
|
National Institutes of Health (NIH) State-of-the-Science Panel Seeks to Dispel Stigma Associated With Fecal and Urinary Incontinence 12/13/2007
More...
|
Cell Transplants May Improve Severe Urinary Incontinence 11/13/2007
More...
|
Removal Of Uterus Increases Risk Of Urinary Incontinence 10/30/2007
More...
|
New Male Sling Procedure Helps Prostate Cancer Survivors Who Suffer from Urinary Incontinence 8/29/2007
More...
|
Acute Sleep Deprivation Leads To Changes In Nighttime Urine Production For Men And Women 8/9/2007
More...
|
Q-Med AB Announces Top-Line Results of North American Clinical Study of ZUIDEX 7/12/2007
More...
|
Q-Med AB Announces Results of North American Clinical Study of ZUIDEX 7/12/2007
More...
|
American Medical Systems, Inc. (AMMD) Expands Global Clinical Evaluation of MiniArc(TM) Single Incision Sling for Female Stress Urinary Incontinence 6/14/2007
More...
|
A Simple Injection of Stem Cells from a Woman's Own Muscle May be an Effective Long-Term Treatment for Urinary Incontinence, University of Pittsburgh Study Finds 5/22/2007
More...
|
Sling Surgery is More Effective than Burch for Bladder Control in Women 5/22/2007
More...
|
Minimally Invasive Device Shows Promise in Treating Female Urinary Incontinence, Emory University Study Finds 5/22/2007
More...
|
New Trial of Novasys Medical, Inc.'s Renessa(R) Treatment Studies Women Who Have Failed Previous Surgical Procedures for Stress Urinary Incontinence 5/17/2007
More...
|
Cornell University's Quick, Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy 5/14/2007
More...
|
IMPAX Laboratories, Inc. (IPXL) Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg 5/9/2007
More...
|
American Medical Systems, Inc. (AMMD) Has Initiated a Clinical Evaluation for a New Minimally Invasive Sling Intended to Treat Female Stress Urinary Incontinence 3/22/2007
More...
|
Enrollment Completed In Post-Market Study Of Novasys Medical, Inc.'s Renessa(R) Treatment For Stress Urinary Incontinence 12/20/2006
More...
|
Uroplasty, Inc. (UPST) Announces Distribution Agreement For EasyCont P/Q(TM) Incontinence Diagnostic Device 12/4/2006
More...
|
IMPAX Laboratories, Inc. (IPXL) Receives Final FDA Approval And First-To-File Status For Generic Version Of Ditropan(R) XL 15 Mg 11/10/2006
More...
|
Uroplasty, Inc. (UPST) Receives FDA Approvable Letter For Macroplastique 9/13/2006
More...
|
IMPAX Laboratories, Inc. (IPXL) Prevails In ALZA Corporation (JNJ)s Appeal Related To Generic Version Of Ditropan(R) XL 9/7/2006
More...
|
Ethicon, Inc. (JNJ) Introduces New Device To Treat Stress Incontinence 9/5/2006
More...
|
Injecting Stem Cells From A Woman's Own Muscle May Effectively Treat Urinary Incontinence 5/30/2006
More...
|
Injecting Stem Cells From A Woman's Own Muscle May Effectively Treat Urinary Incontinence 5/22/2006
More...
|
One Fourth Of Older Patients Receive Catheters For No Reason 5/22/2006
More...
|
Enhance Biotech Inc. Announces Asset Sale Agreement With Mount Cook Biosciences For Delta Receptor Portfolio 5/22/2006
More...
|
Siemens Medical Solutions Brings Patient-Centered Care And Productivity To Urologists At AUA 2006 5/19/2006
More...
|
Sosei Co., Ltd. Discontinues Development Of SOU-001 5/15/2006
More...
|
Kissei Pharmaceutical Co., Ltd. And Daiichi Pharmaceutical (JPN) Jointly Launch Urination Disorder Improving Drug 5/12/2006
More...
|
Urology Device Company, Percutaneous Systems Inc. Flush With $5 Million Series C 5/11/2006
More...
|
Ethicon, Inc. (JNJ) Announces CE Mark Approval Of New Device To Treat Female Stress Incontinence 5/11/2006
More...
|
UroToday Release: First Pelvic Prolapse Surgery Demonstrating Prevention Of Urinary Incontinence 4/19/2006
More...
|
Pfizer Inc. (PFE) To Buy Schwarz Pharma Bladder Drug For $210 Million; Schwarz Shares Surge 4/13/2006
More...
|
Safetek International Inc. To Develop Novel Selective Muscarinic Receptor Antagonist For Over Active Bladder 4/11/2006
More...
|
Stellar Pharmaceuticals Inc. (SLX.V) Announces Presentation Of NMP22'R' BladderChek'R' Test At The 21st Annual Congress Of The European Association Of Urology 4/10/2006
More...
|
Depomed, Inc. (DEPO) And Madaus S.r.l. Announce Acceptance Of The Application For Approval Of ProQuin(R) XR In Sweden 3/29/2006
More...
|
Nippon Chemiphar Co., Ltd. And Torii Pharmaceutical Co. To Terminate Sales Tie-Up For Urinary Alkalizer 3/14/2006
More...
|
Indevus Pharmaceuticals, Inc. (IDEV) Provides Update On Two Clinical Programs; Company Completes Enrollment In Phase II Trial For Pagoclone And First Phase III Trial For SANCTURA XR(TM) 3/7/2006
More...
|
Herb Not Effective For Enlarged Prostate 2/9/2006
More...
|
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Release: Recruitment Of Patients For The Phase II Study In Stress Urinary Incontinence With Cizolirtine Drug Has Been Completed 2/3/2006
More...
|
SS Pharmaceutical Co. Ltd. To Market New Urination Disorder Drug 1/30/2006
More...
|
Antares Pharma, Inc. (ANTR) Completes The Phase II Clinical Trial For Anturol(TM) 1/3/2006
More...
|
Antares Pharma, Inc. (ANTR) Reports Progress With Anturol(TM) Oxybutynin Gel 12/13/2005
More...
|
Cranberry Compound Found To Block Cancer 10/17/2005
More...
|
Collagen Injections Help Men With Incontinence 9/9/2005
More...
|
Indevus Pharmaceuticals, Inc. (IDEV) Initiates Phase III Clinical Program For SANCTURA XR(TM) In Overactive Bladder; Indevus Receives $10 Million Milestone Payment From Esprit Pharma Inc. 9/8/2005
More...
|
Antares Pharma, Inc. (ANTR) Initiates Phase II Clinical Trial For Its Overactive Bladder Transdermal Product, Anturol(TM) (AP 1034) 9/7/2005
More...
|
Hollister Incorporated Release: The evadri Bladder Control System Offers Treatment Without Drugs Or Surgery 7/5/2005
More...
|
American Botanical Council, Austin Releaes: Saw Palmetto And Nettle Root Combination Effective For Prostate And Urinary Problems In Elderly Men 7/5/2005
More...
|
Sosei Co., Ltd.'s SOU-001 Project Moves To Phase II Clinical Study 6/20/2005
More...
|
LifeTree eClinical Selected For Urinary Incontinence Study 6/16/2005
More...
|
Watson Pharmaceuticals, Inc. (WPI) Commences Phase 3 Studies On Silodosin For Treatment Of Benign Prostatic Hyperplasia 6/13/2005
More...
|
Nymox Pharmaceutical (NYMX) Reports Positive New Data For BPH Drug 6/8/2005
More...
|
Novavax, Inc. (NVAX) Expands Pipeline With Pre-Clinical Results For Two New Compounds 6/8/2005
More...
|
Botox May Help Incontinence, Study Indicates 5/25/2005
More...
|
MediciNova, Inc. Initiates A Phase II Clinical Trial With MN-001 In Interstitial Cystitis 5/24/2005
More...
|
Depomed, Inc. (DEPO) Announces Extended Phase II Results For Furosemide GR In Congestive Heart Failure Patients; Edema Data Disappoints, Shows Furosemide GR Does Not Improve Urination Consistency 5/13/2005
More...
|
American Oriental Bioengineering, Inc. (AOBO.OB) Signs Letter Of Intent To Acquire Pharmaceutical Wholesale And Retail Company 5/6/2005
More...
|
American Urological Association And Elsevier Announce New Partnership 4/26/2005
More...
|
Uroplasty, Inc. (UPST) Raises $7.5 Million In Private Placement Of Common Stock And Warrants 4/22/2005
More...
|
Bioniche Life Sciences Inc. (BNC.TO) Presents Data On Prevention And Management Of Urinary Tract Infections Using Cystistat(R) 4/18/2005
More...
|
Boehringer Ingelheim Corporation Release: Unique New Study Suggests Significant Benefits Of Yentreve® In Combination With Pelvic Floor Muscle Training For Women With Stress Urinary Incontinence 4/11/2005
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) And Toray Industries, Inc. To Develop Investigational Compound For Frequent Urination / Urinary Incontinence 4/7/2005
More...
|
4SC AG And Schwarz Pharma Agree On Long-Term Research Cooperation 4/5/2005
More...
|
Barr Pharmaceuticals, Inc. (BRL) Says Court Rejects Ciprofloxacin Antitrust Class Action Suits 4/1/2005
More...
|
Ranbaxy Laboratories Receives FDA Approval To Market A Generic Alternative To Macrobid(R) 4/1/2005
More...
|
Valera Pharmaceuticals Files IPO Of Up To $74.75 Million 3/14/2005
More...
|
Hormone Pills May Make Incontinence Worse 2/23/2005
More...
|
Sosei Co., Ltd. In-License Urology Drug From Otsuka Pharmaceutical Co., Ltd. 2/23/2005
More...
|
IMPAX Laboratories, Inc. (IPXL) Receives Tentative FDA Approval For Generic Version Of Ditropan XL; First Approval In 2005 2/2/2005
More...
|
WellSpring Pharmaceutical Corporation Receives FDA Clearance To Market Duvoid(R) Brand Of Bethanechol 50mg Strength 2/1/2005
More...
|
Micro Therapeutics, Inc. (MTIX) Receives $3.7 Million Payment 2/1/2005
More...
|
Eli Lilly and Company (LLY) And Boehringer Ingelheim GmbH Jointly Announce The Recision Of U.S. FDA Application For Duloxetine For Treatment Of Stress Urinary Incontinence 1/28/2005
More...
|
Nanobac Life Sciences, Inc. Announces Prominent Research Studies Link Nanobacteria Infection To Urological Diseases 1/26/2005
More...
|
Dynogen Pharmaceuticals, Inc. Awarded Broad U.S. Patent Relating To Treatment Of Lower Urinary Tract Disorders 1/25/2005
More...
|
EpiPharma, Inc. (EPHM) Release: Clinical Trial Planned For Stem Cell Treatment For Stress Urinary Incontinence 1/21/2005
More...
|
Yamanouchi Pharmaceutical Co., Ltd. To Market Vesicare For Treatment Of Overactive Bladder In U.S 1/21/2005
More...
|
FemmePharma, Inc. Creates New Holding Company And Subsidiary 1/18/2005
More...
|
Novartis Pharmaceuticals Corporation (NVS) Release: FDA Approves Enablex For Treatment Of Overactive Bladder 12/23/2004
More...
|
Kissei Pharmaceutical Co., Ltd. Enters SILODOSIN European License With Recordati S.p.A 12/14/2004
More...
|
Pfizer Inc. (PFE) Release: Long-Term Data Show Benefit Of DETROL LA As First-Line Therapy For Overactive Bladder 12/13/2004
More...
|
Eli Lilly and Company (LLY) Profiles Its Exceptional New Product Flow And Pipeline To Wall Street 12/9/2004
More...
|
ETHICON, INC. (JNJ) Release: Bonnie Blair Breaks The Ice About Stress Urinary Incontinence; U.S. Speed Skater Hopes To Educate Women About This Common Post-Childbirth Condition
12/2/2004
More...
|
Stem Cells Used To Aid Continence 11/30/2004
More...
|
ETHICON, INC. (JNJ) Release: New Study Shows Minimally-Invasive Surgery For Female Incontinence Offers Good Long-Term Cure Rates 11/30/2004
More...
|
I'rom, Takeshiba Electrics Conclude Exclusive Sales Agreement For Urine Output Measuring Device 11/18/2004
More...
|
FemmePharma, Inc. Named Company To Watch By Eastern Technology Council 11/12/2004
More...
|
Novartis Pharma AG (NVS) Receives European Marketing Authorization For Emselex(R) 10/27/2004
More...
|
BioXell S.p.A. Raises EUR 23 Million In Its Third Round Of Private Financing 10/20/2004
More...
|
Bayer Pharmaceuticals Corporation (CT) Release: Cipro(R) XR (ciprofloxacin extended-release) Demonstrates Rapid Symptom Improvement And Early Return To Activities In Women Suffering From Uncomplicated Urinary Tract Infections (uUTI) 10/18/2004
More...
|
Pfizer Inc. (PFE) Launches Nationwide Education Campaign With Olympic Gymnast Mary Lou Retton To Raise Awareness Of Overactive Bladder 9/29/2004
More...
|
Drug May Avert Surgery For Severe Incontinence 9/17/2004
More...
|
Eli Lilly and Company (LLY) And Boehringer Ingelheim GmbH Release: Yentreve®, First And Only Widely Approved Pharmaceutical Option For The Treatment Of Stress Urinary Incontinence Is Now Available 9/13/2004
More...
|
Uroplasty, Inc. (UPST) Announces Exclusive Manufacturing And Marketing Agreement For Stress Urinary Incontinence Product 9/9/2004
More...
|
Indevus Pharmaceuticals, Inc. (IDEV) Release: Data On SANCTURA For Overactive Bladder Show Treated Patients Do Not Experience Daytime Sleepiness 8/26/2004
More...
|
Indevus Pharmaceuticals, Inc. (IDEV) And Odyssey Pharmaceuticals, Inc. Release: New Data Presented At International Continence Society Show SANCTURA Improves All Classic Symptoms Of Overactive Bladder And Is Well Tolerated By Hepatically Impaired Subjects 8/26/2004
More...
|
Indevus Pharmaceuticals, Inc. (IDEV) And Odyssey Pharmaceuticals, Inc. Release: SANCTURA Launched For Overactive Bladder; New Treatment Now Available For 33 Million Americans Living With Overactive Bladder 8/23/2004
More...
|
Pfizer Inc.'s (PFE) DETROL(R) LA Effectively Treats Overactive Bladder Symptoms Of Mixed Incontinence, The Most Common Type Of Urinary Incontinence 8/20/2004
More...
|
Indevus Pharmaceuticals, Inc. (IDEV) And Odyssey Pharmaceuticals, Inc. Announce Initiation Of U.S. Distribution Of SANCTURA; Launch Date Set For August Companies Provide Update On Launch Activities 8/11/2004
More...
|
Botox May Treat Urinary Incontinence 8/2/2004
More...
|
GlaxoSmithKline (GSK) And Yamanouchi Pharmaceutical Co., Ltd. Release: New Data Show Once-Daily Solifenacin Succinate Significantly Reduced Urgency Episodes For Patients With Overactive Bladder 7/30/2004
More...
|
Eli Lilly and Company (LLY) And Boehringer Ingelheim Pharmaceuticals, Inc. Release Duloxetine Clinical Study Results Show Improvement In Stress Urinary Incontinence In Women 7/29/2004
More...
|
Indevus Pharmaceuticals, Inc. (IDEV) Announces Favorable Results Of Long-Term Use Of SANCTURA; Continued Use Results In Long-Term Efficacy And Improved Tolerability 7/29/2004
More...
|
Able Laboratories (ABRX) Receives Four FDA Approvals For Bethanechol Chloride Tablets, USP 5mg, 10mg, 25mg and 50mg 7/28/2004
More...
|
Boehringer Ingelheim Pharmaceuticals, Inc. Release: Multiple Clinical Trial Analysis Shows Duloxetine Reduces Stress Urinary Incontinence Episodes 6/29/2004
More...
|
Health Canada Approves Watson Pharmaceuticals' (WPI) OXYTROL For The Treatment Of Overactive Bladder 6/24/2004
More...
|
Watson Pharmaceuticals' (WPI) Transdermal Therapy For Urge Incontinence Approved For Marketing In The European Union 6/21/2004
More...
|
Pfizer Inc. (PFE) Release: New Validated Eight-Question Screening Tool To Help Identify Patients With Overactive Bladder 6/15/2004
More...
|
Pliva Pharmaceutical Company Announces FDA Approval Of SANCTURA 6/1/2004
More...
|
Boehringer Ingelheim Pharmaceuticals, Inc. Release: 87% Of Patients Not Responding To Herbal Treatments for Urinary Symptoms Satisfied Following Treatment With FLOMAX 5/12/2004
More...
|
Botox Treats Bladder Problems 5/11/2004
More...
|
GlaxoSmithKline (GSK) And Yamanouchi Pharmaceutical Co., Ltd. Release: Once-Daily Solifenacin Succinate Improved Key Symptoms of Overactive Bladder In Women 5/4/2004
More...
|
Barr Pharmaceuticals, Inc. (BRL) Acquires Rights To Urinary Incontinence Transvaginal Ring Product From Schering AG, (SHR) Germany; Gains Worldwide Rights To Product And Records Charge Of $22 Million Related To Termination Of An Existing License Agreement 4/5/2004
More...
|
SkyePharma Inc. (SKYE) Release: European Urology Conference Hears Data On Use Of Xatral OD In Acute Urinary Retention 3/29/2004
More...
|
Darifenacin Significantly Improves Overactive Bladder Symptoms, Does Not Impair Cognitive Function 3/26/2004
More...
|
Sanofi-Synthelabo SA - France (LS:SNF) Release: Alfuzosin 10 mg OD (Xatral OD) Shows Beneficial Effect In Patients With Acute Urinary Retention 3/25/2004
More...
|
Collagen Level Can Impact Risk Of Incontinence And Prolapse In Women 3/22/2004
More...
|
New Help For Urinary Dysfunction 3/11/2004
More...
|
Antares Pharma, Inc. (ANTR) Announces Completion Of A Phase I Trial For Oxybutynin Topical Gel Utilizing Its ATD(TM) Gel Delivery System 3/11/2004
More...
|
Gynecare Introduces Diagnostic Device For Female Incontinence 3/5/2004
More...
|
New Study Shows Gynecare TVT Equal To Burch Surgery For Female Incontinence Treatment 2/26/2004
More...
|
Volunteers Exit Drug Trial After Suicide; Nearly One-Fifth Drop Out Of Eli Lilly and Company (LLY) Antidepressant Drug Trial After Participant's Suicide 2/12/2004
More...
|
Eli Lilly and Company (LLY) And Boehringer Ingelheim Pharmaceuticals, Inc. Release: Large-Scale Study In The British Journal Of Urology Shows More Than One Out Of Three Women With Urinary Incontinence Suffer From Stress Urinary Incontinence 2/9/2004
More...
|
FemmePharma, Inc. And Emory University Team To Identify Topical Microbicides For Drug Development 2/9/2004
More...
|
Diagnostic Ultrasound Corporation Introduces Prosthetic Bladder Management Device 2/4/2004
More...
|
ETHICON, INC. (JNJ) Release: New Gynecare Device Introduces Unique "Inside-Out" Obturator Approach To Treat Stress Incontinence 1/26/2004
More...
|
Watson Pharmaceuticals (WPI) Enters Into Licensing Agreement With Paladin Labs Inc. (CC:PLB) For OXYTROL(R) In Canada 1/8/2004
More...
|
Cesarean Section Can Prevent Anal Incontinence 12/29/2003
More...
|
Incontinence Drug May Mar Memory; It's Linked To Recall Problems, Hallucinations In Elderly Patient 12/4/2003
More...
|
Neurogen (NRGN) And Merck & Co. (MRK) Form Alliance To Develop Next-Generation Drugs For Pain And Other Disorders 12/1/2003
More...
|
Prostate Symptoms May Worsen Rapidly For Black Men 11/19/2003
More...
|
Painful Pelvic Disorder Linked To Small Adrenal Glands 11/7/2003
More...
|
ADHD Drug May Help Curb Bed-Wetting 11/4/2003
More...
|
American Medical Systems, Inc. (AMMD) Release: New Data Reveals That SPARC Sling System Is A Safe And Effective Treatment For Female Stress Urinary Incontinence 11/3/2003
More...
|